Latest News about FDA
Recent news which mentions FDA
From Benzinga
FDA Adcomm Gives Thumbs Down To Cytokinetics' Heart Failure Candidate
December 14, 2022
Tickers
CYTK
From Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
December 13, 2022
Tickers
MRTX
From Benzinga
Biotricity Files FDA 510(k) For Expanded Use Of Its Biotres Cardiac Monitoring Device
December 12, 2022
Tickers
BTCY
From Benzinga
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
December 09, 2022
Tickers
CMPS
From Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
November 30, 2022
Tickers
REGN
From Benzinga
Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease
November 30, 2022
Tickers
AGLE
From Benzinga
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Tickers
SPPI
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.